Tevimbra 유럽 연합 - 이탈리아어 - EMA (European Medicines Agency)

tevimbra

novartis europharm limited - tislelizumab - esophageal squamous cell carcinoma - agenti antineoplastici - oesophageal squamous cell carcinoma (oscc) tevimbra as monotherapy is indicated for the treatment of adult patients with unresectable, locally advanced or metastatic oesophageal squamous cell carcinoma after prior platinum-based chemotherapy.

NERVOUP 이탈리아 - 이탈리아어 - Ministero della Salute

nervoup

farmacia carbone sas - apparato osteoarticolare

Xalkori 유럽 연합 - 이탈리아어 - EMA (European Medicines Agency)

xalkori

pfizer europe ma eeig - crizotinib - carcinoma, polmone non a piccole cellule - agenti antineoplastici - xalkori as monotherapy is indicated for:the first‑line treatment of adults with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with previously treated anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with ros1‑positive advanced non‑small cell lung cancer (nsclc)the treatment of paediatric patients (age ≥6 to.